ClinicalTrials.Veeva

Menu

Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database. (Relax)

Ipsen logo

Ipsen

Status

Completed

Conditions

Post Stroke Spasticity

Study type

Observational

Funder types

Industry

Identifiers

NCT04649632
CLIN-52120-450

Details and patient eligibility

About

Determining the mean/median time between botulinum toxin-A injection within the treatment of patients with spasticity after stroke in relation to the botulinum toxin dose from a healthcare insurance database in the Netherlands.

Enrollment

451 patients

Sex

All

Ages

25+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A patient will be included if he has a diagnosis stroke within the rehabilitation setting and has received at least two injections of botulinum toxin-A: Dysport or Botox

Exclusion criteria

  • A patient will be excluded if he has been only treated with Xeomin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems